Free Trial

Analysts Issue Forecasts for Astrana Health Q1 Earnings

Astrana Health logo with Medical background

Astrana Health, Inc. (NASDAQ:ASTH - Free Report) - Analysts at William Blair issued their Q1 2026 EPS estimates for shares of Astrana Health in a research note issued to investors on Wednesday, July 2nd. William Blair analyst R. Daniels expects that the company will earn $0.34 per share for the quarter. The consensus estimate for Astrana Health's current full-year earnings is $1.15 per share. William Blair also issued estimates for Astrana Health's Q4 2026 earnings at $0.48 EPS.

Astrana Health (NASDAQ:ASTH - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported $0.14 EPS for the quarter, missing analysts' consensus estimates of $0.23 by ($0.09). Astrana Health had a net margin of 1.56% and a return on equity of 4.90%. The firm had revenue of $620.39 million during the quarter, compared to the consensus estimate of $628.11 million. During the same quarter in the previous year, the company posted $0.31 earnings per share. The firm's revenue was up 53.4% on a year-over-year basis.

Other research analysts also recently issued research reports about the company. Truist Financial lowered their price objective on Astrana Health from $50.00 to $46.00 and set a "buy" rating for the company in a research note on Tuesday, March 18th. Barclays assumed coverage on shares of Astrana Health in a research report on Tuesday, April 1st. They issued an "equal weight" rating and a $36.00 price target for the company. Three research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $53.29.

Read Our Latest Stock Report on Astrana Health

Astrana Health Trading Up 2.5%

Astrana Health stock traded up $0.63 during trading hours on Thursday, hitting $25.28. The stock had a trading volume of 159,835 shares, compared to its average volume of 297,884. The business's 50 day simple moving average is $26.65 and its 200-day simple moving average is $30.70. Astrana Health has a one year low of $23.12 and a one year high of $63.20. The stock has a market cap of $1.42 billion, a price-to-earnings ratio of 35.10, a P/E/G ratio of 1.36 and a beta of 0.84. The company has a quick ratio of 1.70, a current ratio of 1.70 and a debt-to-equity ratio of 0.54.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in ASTH. Truist Financial Corp bought a new stake in shares of Astrana Health during the 4th quarter valued at about $315,000. US Bancorp DE boosted its holdings in shares of Astrana Health by 3,880.0% during the 4th quarter. US Bancorp DE now owns 4,776 shares of the company's stock worth $151,000 after buying an additional 4,656 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in shares of Astrana Health by 5.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 471,329 shares of the company's stock worth $14,861,000 after buying an additional 23,533 shares in the last quarter. Victory Capital Management Inc. grew its position in shares of Astrana Health by 38.6% during the 4th quarter. Victory Capital Management Inc. now owns 62,116 shares of the company's stock worth $1,959,000 after buying an additional 17,310 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of Astrana Health by 348.1% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 37,788 shares of the company's stock valued at $1,191,000 after acquiring an additional 29,355 shares in the last quarter. 52.77% of the stock is owned by institutional investors.

Astrana Health Company Profile

(Get Free Report)

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.

Featured Stories

Should You Invest $1,000 in Astrana Health Right Now?

Before you consider Astrana Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Astrana Health wasn't on the list.

While Astrana Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore
AI Stocks Are Printing Money — These 3 Are Just Getting Started

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines